Ireland moves to further tackle female CV (cardiovascular) disease
This article was originally published in Clinica
There is a need to develop models of care that better take account of the high incidence of cardiovascular (CV) disease among women. So said Ireland's health minister yesterday (April 22 2004), during the launch of a conference to debate the issue.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.